Today, Serene LLC’s veterinary subsidiary, Convetra Inc, completed enrollment of its second clinical trial using Synovetin-OA in client owned dogs with grade 3 osteoarthritis of the elbow. These subjects will be followed for 12 months, with results anticipated in 2018.